Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 20 putative open reading frame 181 (C20orf181, also known as dJ824A14.1) is a human gene of currently unclear function. It is described as an intronless gene, with reported specific expression in dendritic cells, which are potent antigen-presenting cells of the immune system[4][5][9]. There is no evidence from current resources that it encodes a known receptor, enzyme, transporter, or other recognized drug-target class, nor is it linked to specific diseases or therapeutic roles[2][3][4][7]. It is also not referenced as a biomarker or as having any specific interacting drugs or known mechanisms of action. The gene is categorized as "uncategorized" or "putative," reflecting a lack of functional characterization[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 20 putative open reading frame 181 (C20orf181).